4-aminopyridine has been researched along with External Ophthalmoplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanhai, KMS | 1 |
| Nij Bijvank, JA | 1 |
| Wagenaar, YL | 1 |
| Klaassen, ES | 1 |
| Lim, K | 1 |
| Bergheanu, SC | 1 |
| Petzold, A | 1 |
| Verma, A | 1 |
| Hesterman, J | 1 |
| Wattjes, MP | 1 |
| Uitdehaag, BMJ | 1 |
| van Rijn, LJ | 1 |
| Groeneveld, GJ | 1 |
| Serra, A | 1 |
| Skelly, MM | 1 |
| Jacobs, JB | 1 |
| Walker, MF | 1 |
| Cohen, JA | 1 |
1 trial available for 4-aminopyridine and External Ophthalmoplegia
| Article | Year |
|---|---|
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.
Topics: 4-Aminopyridine; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle | 2019 |
1 other study available for 4-aminopyridine and External Ophthalmoplegia
| Article | Year |
|---|---|
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Topics: 4-Aminopyridine; Adult; Eye Movements; Humans; Male; Middle Aged; Multiple Sclerosis; Ophthalmoplegi | 2014 |